Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Breast Cancer Mortality and Age at Diagnosis

David J. Biau, MD, PhD; Raphael Porcher, PhD
JAMA. 2012;307(19):2023-2024. doi:10.1001/jama.2012.3613.
Text Size: A A A
Published online


To the Editor: The study by Dr van de Water and colleagues1 found that increasing age was associated with higher breast cancer mortality in postmenopausal women with hormone receptor–positive tumors. There are methodological issues in measuring the effect of age on disease-specific mortality.

Classifying patients on the basis of whether there was evidence of breast cancer at the time of their death may be misleading. For instance, if an 80-year-old woman with a known pulmonary metastasis dies, her death will be attributed to breast cancer. However, without a postmortem examination, it is not possible to determine the exact cause of death, which may be due to a non–disease-specific condition such as unstable coronary artery disease. If a 36-year-old woman with breast cancer dies in a motor vehicle crash, it will be impossible without a postmortem examination to definitively determine whether the death is due to the motor vehicle crash or to a complication of her malignancy, such as a pulmonary tumor embolism.2


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




May 16, 2012
Willemien van de Water, MD; Gerrit-Jan Liefers, MD, PhD; Cornelius J. H. van de Velde, MD, PhD
JAMA. 2012;307(19):2023-2024. doi:10.1001/jama.2012.3645.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.